-
1
-
-
2442563304
-
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
-
Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1,504-1,517.
-
(2004)
Gastroenterology
, vol.126
, pp. 1504-1517
-
-
Loftus, E.V.1
-
2
-
-
4143069158
-
High prevalence of adherentinvasive Escherichia coli associated with ileal mucosa in Crohn's disease
-
Darfeuille-Michaud A, Boudeau J, Bulois P et al. High prevalence of adherentinvasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-421.
-
(2004)
Gastroenterology
, vol.127
, pp. 412-421
-
-
Darfeuille-Michaud, A.1
Boudeau, J.2
Bulois, P.3
-
3
-
-
33745413808
-
Probiotics and inflammatory bowel diseases
-
Bai AP, Ouyang Q. Probiotics and inflammatory bowel diseases. Postgrad Med J 2006; 82: 376-382.
-
(2006)
Postgrad Med J
, vol.82
, pp. 376-382
-
-
Bai, A.P.1
Ouyang, Q.2
-
4
-
-
0031815046
-
Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine
-
Steidler L, Robinson K, Chamberlain L et al. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 1998; 66: 3,183-3,189.
-
(1998)
Infect Immun
, vol.66
, pp. 3183-3189
-
-
Steidler, L.1
Robinson, K.2
Chamberlain, L.3
-
6
-
-
0034714188
-
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
-
Steidler L, Hans W, Schotte L et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289: 1,352-1,355.
-
(2000)
Science
, vol.289
, pp. 1352-1355
-
-
Steidler, L.1
Hans, W.2
Schotte, L.3
-
7
-
-
33744933432
-
A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease
-
Braat H, Rottiers P, Hommes DW et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 2006; 4: 754-759.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 754-759
-
-
Braat, H.1
Rottiers, P.2
Hommes, D.W.3
-
8
-
-
0037820426
-
Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
-
Steidler L, Neirynck S, Huyghebaert N et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 2003; 21: 785-789.
-
(2003)
Nat Biotechnol
, vol.21
, pp. 785-789
-
-
Steidler, L.1
Neirynck, S.2
Huyghebaert, N.3
-
9
-
-
40049097099
-
Epithelial restitution and wound healing in inflammatory bowel disease
-
Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol 2008; 14: 348-353.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 348-353
-
-
Sturm, A.1
Dignass, A.U.2
-
10
-
-
17644378995
-
Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin-2 in response to xylan
-
Farrar MD, Whitehead TR, Lan J et al. Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin-2 in response to xylan. J Appl Microbiol 2005; 98: 1,191-1,197.
-
(2005)
J Appl Microbiol
, vol.98
, pp. 1191-1197
-
-
Farrar, M.D.1
Whitehead, T.R.2
Lan, J.3
-
11
-
-
55549088221
-
Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins
-
Hamady ZZ, Farrar M, Whitehead TR et al. Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins. Microbiology 2008; 154: 3,165-3,174.
-
(2008)
Microbiology
, vol.154
, pp. 3165-3174
-
-
Hamady, Z.Z.1
Farrar, M.2
Whitehead, T.R.3
-
12
-
-
77950799444
-
Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus
-
Hamady ZZ, Scott N, Farrar MD et al. Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut 2010; 59: 461-469.
-
(2010)
Gut
, vol.59
, pp. 461-469
-
-
Hamady, Z.Z.1
Scott, N.2
Farrar, M.D.3
-
13
-
-
80051504591
-
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1
-
Hamady ZZ, Scott N, Farrar MD et al. Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1. Inflamm Bowel Dis 2011; 17: 1,925-1,935.
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 1925-1935
-
-
Hamady, Z.Z.1
Scott, N.2
Farrar, M.D.3
-
14
-
-
0020681426
-
Bacterial populations associated with different regions of the human colon wall
-
Croucher SC, Houston AP, Bayliss CE, Turner RJ. Bacterial populations associated with different regions of the human colon wall. Appl Environ Microbiol 1983; 45: 1,025-1,033.
-
(1983)
Appl Environ Microbiol
, vol.45
, pp. 1025-1033
-
-
Croucher, S.C.1
Houston, A.P.2
Bayliss, C.E.3
Turner, R.J.4
-
15
-
-
0019445483
-
Utilization of xylan by two species of human colonic Bacteroides
-
Salyers AA, Gherardini F, O'Brien M. Utilization of xylan by two species of human colonic Bacteroides. Appl Environ Microbiol 1981; 41: 1,065-1,068.
-
(1981)
Appl Environ Microbiol
, vol.41
, pp. 1065-1068
-
-
Salyers, A.A.1
Gherardini, F.2
O'Brien, M.3
-
16
-
-
0025273798
-
The genes for three xylan-degrading activities from Bacteroides ovatus are clustered in a 3.8-kilobase region
-
Whitehead TR, Hespell RB. The genes for three xylan-degrading activities from Bacteroides ovatus are clustered in a 3.8-kilobase region. J Bacteriol 1990; 172: 2,408-2,412.
-
(1990)
J Bacteriol
, vol.172
, pp. 2408-2412
-
-
Whitehead, T.R.1
Hespell, R.B.2
-
18
-
-
2642532099
-
Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells
-
Visco V, Belleudi F, Marchese C et al. Differential response to keratinocyte growth factor receptor and epidermal growth factor receptor ligands of proliferating and differentiating intestinal epithelial cells. J Cell Physiol 2004; 200: 31-44.
-
(2004)
J Cell Physiol
, vol.200
, pp. 31-44
-
-
Visco, V.1
Belleudi, F.2
Marchese, C.3
-
19
-
-
2542473235
-
Differential trafficking of transforming growth factor-beta receptors and ligand in polarized epithelial cells
-
Murphy SJ, Doré JJ, Edens M et al. Differential trafficking of transforming growth factor-beta receptors and ligand in polarized epithelial cells. Mol Biol Cell 2004; 15: 2,853-2,862.
-
(2004)
Mol Biol Cell
, vol.15
, pp. 2853-2862
-
-
Murphy, S.J.1
Doré, J.J.2
Edens, M.3
-
20
-
-
0029995799
-
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance
-
Neurath MF, Fuss I, Kelsall BL et al. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996; 183: 2,605-2,616.
-
(1996)
J Exp Med
, vol.183
, pp. 2605-2616
-
-
Neurath, M.F.1
Fuss, I.2
Kelsall, B.L.3
-
21
-
-
0033673940
-
Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats
-
Han DS, Li F, Holt L et al. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1011-G1022.
-
(2000)
Am J Physiol Gastrointest Liver Physiol
, vol.279
-
-
Han, D.S.1
Li, F.2
Holt, L.3
-
22
-
-
0035895767
-
Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards
-
Epstein SE, Fuchs S, Zhou YF et al. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 2001; 49: 532-542.
-
(2001)
Cardiovasc Res
, vol.49
, pp. 532-542
-
-
Epstein, S.E.1
Fuchs, S.2
Zhou, Y.F.3
-
23
-
-
0025632985
-
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution
-
Wakefield LM, Winokur TS, Hollands RS et al. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 1990; 86: 1,976-1,984.
-
(1990)
J Clin Invest
, vol.86
, pp. 1976-1984
-
-
Wakefield, L.M.1
Winokur, T.S.2
Hollands, R.S.3
|